E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder.
Pall, M L, Satterlee, J D · Annals of the New York Academy of Sciences · 2001 · DOI
Quick Summary
This theory paper proposes that ME/CFS, multiple chemical sensitivity (MCS), and post-traumatic stress disorder may share a common cause: abnormally high levels of nitric oxide and related harmful molecules in the body. The authors suggest that feedback loops—where one problem triggers another, which makes the first worse—could explain why these conditions become chronic and persist over time.
Why It Matters
This study offers a potential unified biochemical mechanism that could explain why ME/CFS, chemical sensitivities, and trauma-related illness often co-occur or cluster in patients. If validated, such a common pathway could guide development of targeted treatments and help legitimize these conditions as biological diseases rather than psychosomatic disorders.
Observed Findings
- Various types of biochemical evidence implicate nitric oxide and peroxynitrite in MCS and chemical intolerance
- Positive feedback loops may explain the chronic and self-perpetuating nature of MCS symptoms
- MCS, CFS, and PTSD share overlapping symptom profiles and may share common biochemical mechanisms
Inferred Conclusions
- Elevated nitric oxide/peroxynitrite may represent a unifying mechanistic explanation for multiple chronic illnesses previously considered separate entities
- Positive feedback loops involving this mechanism could account for the chronic, progressive, and treatment-resistant nature of these conditions
- This framework represents a potential new disease paradigm relevant to understanding chemical intolerance and related illnesses
Remaining Questions
- Do patient cohorts with ME/CFS, MCS, and PTSD show elevated nitric oxide and peroxynitrite levels compared to controls, and do levels correlate with symptom severity?
- What triggers initiation of the proposed feedback loop in susceptible individuals?
- Can therapeutic interventions targeting nitric oxide/peroxynitrite pathways improve outcomes in these patient populations?
- What is the relationship between this mechanism and other proposed ME/CFS pathophysiology (immune dysfunction, mitochondrial impairment, etc.)?
What This Study Does Not Prove
This is a theoretical framework, not an empirical study with patient data or experimental validation. It does not prove that nitric oxide/peroxynitrite elevation actually causes these conditions in humans, nor does it establish whether this mechanism is primary or secondary to other pathological processes. The hypothesis remains speculative until confirmed by direct biochemical measurement and intervention studies.
Tags
Symptom:FatigueSensory Sensitivity
Biomarker:CytokinesBlood Biomarker
Method Flag:Exploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →